Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin

Guan-Yu Zhuo1, Ming-Chi Chen1, Tzu-Yu Lin2

  • 1Institute of Translational Medicine and New Drug Development, China Medical University, Taichung 40402, Taiwan.

Insights

Opioid drugs like morphine alter how μ-opioid (MOP) and nociceptin/orphanin FQ (NOP) receptors interact and move. Morphine enhances MOP-NOP receptor pairing and Erk1/2 phosphorylation, while buprenorphine primarily acts through NOP receptors.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Opioid receptors, including μ-opioid (MOP) and nociceptin/orphanin FQ (NOP) receptors, play crucial roles in pain modulation and other physiological processes.
  • Understanding the complex interactions and signaling pathways of coexpressed opioid receptors is essential for developing targeted therapeutics.

Purpose of the Study:

  • To investigate the effects of opioids on the coexpression and heterodimerization of MOP and NOP receptors.
  • To examine opioid-induced alterations in receptor localization on lipid rafts and Erk1/2 phosphorylation.
  • To elucidate the distinct signaling mechanisms of morphine and buprenorphine through MOP and NOP receptors.

Main Methods:

  • Utilized two-photon microscopy and fluorescence resonance energy transfer (FRET) to assess MOP-NOP receptor proximity and heterodimerization.
  • Employed single-particle tracking (SPT) to analyze the movement of MOP-NOP heterodimers.
  • Conducted immunocytochemistry and immunoblotting to determine receptor localization on lipid rafts and Erk1/2 phosphorylation in HEK 293 cells.

Main Results:

  • Morphine, but not buprenorphine, facilitated MOP-NOP heterodimerization.
  • Both morphine and buprenorphine reduced the mobility of MOP-NOP heterodimers.
  • Morphine enhanced MOP-NOP colocalization on lipid rafts and stimulated Erk1/2 phosphorylation in cells expressing MOP or MOP+NOP receptors.
  • Buprenorphine selectively activated Erk1/2 phosphorylation through NOP receptors.

Conclusions:

  • Opioids can modulate the cellular localization and signaling of coexpressed MOP and NOP receptors.
  • Morphine and buprenorphine exhibit distinct mechanisms in regulating MOP-NOP receptor complex dynamics and downstream signaling.
  • These findings provide insights into the nuanced pharmacology of opioid receptor interactions and signaling pathways.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
711
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
372
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
324
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K